Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[finesand]

A17- you are wrong again w/ your timing here

hope you covering your short position now,
last time you failed on the FDA approval
now the lawsuits will settle as shown.

Further more
- Stock down after FDA approval doesn't prove a thing, we know the new biotech play shorting approved stocks, below $2 was a great buy as usual

- Company never wanted to sell product alone, ever

- Every product is unique, here the membrane of both ingredient generics for compliance. Then this is a mass product not to be sold at super high premium.

Watching your fund's biotech short positions,
but this one is now about to bounce